# Preclinical evaluation of waste-derived pomegranate extract (PWE) as a potential preventing and therapeutic agent for benign prostatic hyperplasia

**Authors:** Valeria Consoli, Agata Grazia D’Amico, Claudio Russo, Emanuele Foderà, Daniela Passarella, Antonio Pecorino, Velia D’Agata, Luca Vanella, Valeria Sorrenti

PMC · DOI: 10.3389/fmolb.2026.1769028 · Frontiers in Molecular Biosciences · 2026-02-19

## TL;DR

This study shows that pomegranate waste extract can reduce inflammation and oxidative stress in a rat model of benign prostatic hyperplasia, suggesting it may be a natural treatment option.

## Contribution

The study introduces pomegranate waste extract as a sustainable, natural chemopreventive agent for BPH.

## Key findings

- PWE restored markers of endothelial dysfunction and oxidative stress to control levels in testosterone-treated rats.
- PWE normalized proteins involved in mitochondrial function and enhanced antioxidant enzymes.
- PWE counteracted testosterone-induced changes in periprostatic adipose tissue.

## Abstract

Benign prostatic hyperplasia (BPH) is a highly prevalent age-related condition, affecting nearly half of men over 60 and up to 80% over 80 years old. Chronic inflammation and oxidative stress are recognized contributors to BPH progression and may facilitate the development of prostate cancer. Growing interest in sustainable, natural chemopreventive agents has highlighted agro-industrial by-products as valuable sources of bioactive compounds.

In this study, we evaluated the protective and therapeutic effects of pomegranate waste extract (PWE), a phytochemical-rich by-product of Mediterranean agri-food processing, in a testosterone-induced rat model of BPH.

Immunohistochemistry and Western blot analyses revealed that testosterone administration reduced the expression of PECAM-1 and increased the levels of NRF2, HO-1, and IL1R1, consistently with endothelial dysfunction, oxidative stress, and inflammation. Co-treatment with PWE restored these markers toward control levels, indicating attenuation of testosterone-driven molecular alterations. Proteomic profiling further demonstrated that testosterone dysregulated proteins involved in mitochondrial function, redox balance, and DNA repair; on the contrary, PWE normalized their levels and enhanced antioxidant enzymes. In periprostatic adipose tissue, PWE counteracted testosterone-induced upregulation of HO-1, NRF2, and GPX4. Overall, PWE mitigates oxidative, inflammatory, and metabolic dysfunctions associated with experimental BPH, supporting its potential as a sustainable natural chemopreventive strategy.

## Linked entities

- **Genes:** PECAM1 (platelet and endothelial cell adhesion molecule 1) [NCBI Gene 5175], GABPA (GA binding protein transcription factor subunit alpha) [NCBI Gene 2551], HMOX1 (heme oxygenase 1) [NCBI Gene 3162], IL1R1 (interleukin 1 receptor type 1) [NCBI Gene 3554], GPX4 (glutathione peroxidase 4) [NCBI Gene 2879]
- **Diseases:** benign prostatic hyperplasia (MONDO:0010811), prostate cancer (MONDO:0005159)
- **Species:** Rattus norvegicus (taxon 10116)

## Full-text entities

- **Genes:** Scd (stearoyl-CoA desaturase) [NCBI Gene 246074] {aka Scd1}, H4c14 (H4 clustered histone 14) [NCBI Gene 295277] {aka H4c16, H4c2, H4f16, Hist2h4, Hist4h4}, Hsd17b6 (hydroxysteroid (17-beta) dehydrogenase 6) [NCBI Gene 286964] {aka Hsd17b9}, Txn1 (thioredoxin 1) [NCBI Gene 116484] {aka Txn}, Il1r1 (interleukin 1 receptor type 1) [NCBI Gene 25663] {aka IL-1R-1, IL-1R-alpha, IL-1RT-1, IL-1RT1}, Hpgds (hematopoietic prostaglandin D synthase) [NCBI Gene 58962] {aka Ptgds2}, SRD5A2 (steroid 5 alpha-reductase 2) [NCBI Gene 6716], Tacstd2 (tumor-associated calcium signal transducer 2) [NCBI Gene 494343] {aka Prp1, Trop2}, Pecam1 (platelet and endothelial cell adhesion molecule 1) [NCBI Gene 29583] {aka CD31, Pecam}, Actb (actin, beta) [NCBI Gene 81822] {aka Actx}, Nfe2l2 (NFE2 like bZIP transcription factor 2) [NCBI Gene 83619], Eef1a1 (eukaryotic translation elongation factor 1 alpha 1) [NCBI Gene 171361] {aka EEF-1, EEF1A, EF1A, Eef1a2, Eef1a2l1, SI}, Adipoq (adiponectin, C1Q and collagen domain containing) [NCBI Gene 246253] {aka Acdc, Acrp30, Adid}, Uchl1 (ubiquitin C-terminal hydrolase L1) [NCBI Gene 29545], Hmox1 (heme oxygenase 1) [NCBI Gene 24451] {aka HEOXG, Heox, Hmox, Ho-1, Ho1, hsp32}, Casp6 (caspase 6) [NCBI Gene 83584] {aka Mch2}, AR (androgen receptor) [NCBI Gene 367] {aka AIS, AR8, DHTR, HPCX3, HUMARA, HYSP1}, Agmo (alkylglycerol monooxygenase) [NCBI Gene 362732] {aka RGD1312038, Tmem195}, Lep (leptin) [NCBI Gene 25608] {aka OB, obese}, Txndc12 (thioredoxin domain containing 12) [NCBI Gene 298370] {aka RGD1305960}, Cldn3 (claudin 3) [NCBI Gene 65130], NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, Il10 (interleukin 10) [NCBI Gene 25325] {aka IL10X, If2a}, Cyp4a3 (cytochrome P450, family 4, subfamily a, polypeptide 3) [NCBI Gene 298423] {aka CYPIVA3, Cyp4a14}
- **Diseases:** microvascular dysfunction (MESH:D017566), metastasis (MESH:D009362), prostatic damage (MESH:D011469), hypertension (MESH:D006973), LUTS (MESH:D059411), BPH (MESH:D011470), epithelial hyperplasia (MESH:D017573), erectile dysfunction (MESH:D007172), endothelial injury (MESH:D057772), PPAT (MESH:D018205), liver injury (MESH:D017093), hyperplasia (MESH:D006965), chronic (MESH:D002908), prostatic injury (MESH:D011472), fibrosis (MESH:D005355), PCa (MESH:D011471), Chronic inflammation (MESH:D007249), mitochondrial dysfunction (MESH:D028361), endothelial dysfunction (MESH:D014652), cancer (MESH:D009369), AD (MESH:D000544), lung cancer (MESH:D008175), carcinogenesis (MESH:D063646), metabolic dysfunctions (MESH:D008659), nocturia (MESH:D053158)
- **Chemicals:** H&amp;E (MESH:D006371), hydrogen peroxide (MESH:D006861), superoxide anion (MESH:D013481), 2,2-dithio-bis-nitrobenzoic acid (-), hematoxylin (MESH:D006416), finasteride (MESH:D018120), urea (MESH:D014508), peroxide (MESH:D010545), Thiol (MESH:D013438), corn oil (MESH:D003314), AB (MESH:C027043), TFA (MESH:D014269), CO2 (MESH:D002245), GSH (MESH:D005978), testosterone propionate (MESH:D043343), polyphenol (MESH:D059808), sucrose (MESH:D013395), doxazosin (MESH:D017292), lipid (MESH:D008055), cysteine (MESH:D003545), dutasteride (MESH:D000068538), alcohol (MESH:D000438), DAB (MESH:C000469), DHT (MESH:D013196), eosin (MESH:D004801), 3,3'-diaminobenzidine (MESH:D015100), ROS (MESH:D017382), calcium (MESH:D002118), H2SO4 (MESH:C033158), formalin (MESH:D005557), flavonoids (MESH:D005419), T (MESH:D014316), tamsulosin (MESH:D000077409), methionine (MESH:D008715), paraffin (MESH:D010232), FA (MESH:C030544), xylene (MESH:D014992), phytosterols (MESH:D010840), LOOH (MESH:D008054), acetonitrile (MESH:C032159), carotenoids (MESH:D002338), water (MESH:D014867), 2-iodoacetamide (MESH:D007460), peptide (MESH:D010455), butylated hydroxytoluene (MESH:D002084), Testosterone (MESH:D013739), iron (MESH:D007501), acetic acid (MESH:D019342), tin (MESH:D014001), xylenol orange (MESH:C016833), DTT (MESH:D004229), ethanol (MESH:D000431)
- **Species:** Paratrichocladius sp. PAT (species) [taxon 315568], Rattus norvegicus (brown rat, species) [taxon 10116], Homo sapiens (human, species) [taxon 9606], Punica granatum (granado, species) [taxon 22663]
- **Mutations:** C-25  C

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12960175/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12960175/full.md

## References

54 references — full list in the complete paper: https://tomesphere.com/paper/PMC12960175/full.md

---
Source: https://tomesphere.com/paper/PMC12960175